Predictors of medication adherence in pediatric inflammatory bowel disease patients at the Stollery Children's Hospital

Canadian Journal of Gastroenterology

Volumn 23, Issue 12, 2009, Pages 811-815

  Kitney, L ^a   Turner, J M ^a   Spady, D ^a   Malik, B ^a   El Matary, W ^a   Persad, R ^a   Huynh, Hien Q ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Crohn's disease; Inflammatory bowel disease; Medication adherence; Pediatrics; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; ENEMA; INFLIXIMAB; MESALAZINE; METHOTREXATE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; AGE; ALTERNATIVE MEDICINE; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE DURATION; DRUG USE; ENTERITIS; FEMALE; HEALTH SURVEY; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; SELF REPORT; VITAMIN SUPPLEMENTATION;

EID: 73349125407     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/536860     Document Type: Article

References (21)

1. Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J Paediatr Child Health 2004;40:681-4.
2. Heuschkel R, Afzal N, Wuerth A, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002;97:382-8.
3. Bernal I, Domenech E, Garcia-Planella, et al. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci 2006;51:2165-9.
4. Sewitch MJ, Leffondre K, Dobkin PL. Clustering patients according to health perceptions: Relationships to psychosocial characteristics and medication nonadherence. J Psychosom Res 2004;56:323-32.
5. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007;102:1417-26.
6. Taddeo D, Egedy M, Frappier J-Y. Adherence to treatment in adolescents. Paediatr Child Health 2008;13:19-24.
7. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535-44.
8. Matsui D. Current issues in pediatric medication adherence. Paediatr Drugs 2007;9:283-8.
9. Oliva-Hemker MM, Abadom V, Cuffari C, Thompson RE. Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease. J Pediatr Gastroenterol Nutr 2007;44:180-4.
10. D'Inca R, Bertomoro P, Mazzocco K, Vettorato MG, Rumiati R, Sturniolo GC. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther 2008;27:166-72.
11. Hawthorne AB, Rubin G, Ghosh S. Review article: Medication non-adherence in ulcerative colitis - strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther 2008;27:1157-66.
12. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
13. Truelove SC ,Witts LJ. Cortisone in ulcerative colitis: Final report on a therapeutic trial. Br Med J 1955;2:1041-8.
14. Hommel KA, Davis CM, Baldassano RN. Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol 2008;33:867-74.
15. Zelikovsky N, Schast AP, Palmer J, Meyers KE. Perceived barriers to adherence among adolescent renal transplant candidates. Pediatr Transplant 200812:300-8.
16. Cerveny P, Bortlik M, Kubena A, Vlcek J, Lakatos PL, Lukas M. Nonadherence in inflammatory bowel disease: Results of factor analysis. Inflamm Bowel Dis 2007;13:1244-9.
17. Eiland LS, Salazar ML, English TM. Caregivers' perspectives when evaluating nonprescription medication utilization in children. Clin Pediatr (Phila) 2008;47:578-87.
18. Ogedegbe G, Schoenthaler A, Fernandez S. Appointment-keeping behavior is not related to medication adherence in hypertensive African Americans. J Gen Intern Med 2007;22:1176-9.
19. Kedia P, Cohen RD. Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis. Ther Clin Risk Manag 2007;3:919-27.
20. Annunziato RA, Emre S, Shneider B, Barton C, Dugan CA, Shemesh E. Adherence and medical outcomes in pediatric liver transplant recipients who transition to adult services. Pediatr Transplant 2007;11:608-14.
21. Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: A randomized controlled trial. Can J Gastroenterol 2005;19:235-44.